Sector
PharmaceuticalsCMP
as on 03 Jul, 2024 12:00:00 AM
Open
₹342Prev. Close
₹340.9Turnover(Lac.)
₹12.89Day's High
₹343.95Day's Low
₹331.352 Week's High
₹533.652 Week's Low
₹320Book Value
₹210.35Face Value
₹10Mkt Cap (₹ Cr.)
103.45P/E
47.83EPS
7Divi. Yield
0.330 May 2023
12:00 AM
AGM
Announcement Date: 30 May, 2023
28 Mar 2024
12:00 AM
Board Meeting
Agenda : Audited Result
30 May 2023
12:00 AM
BookCloser
30 May 2023
12:00 AM
Dividend
Dividend Amount: 1
Record Date: 18 Sep, 2023
| Y/e 31 Mar( In .Cr) | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|
Equity Capital | 3.09 | 3.09 | 3.09 | 3.09 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 60.05 | 43.73 | 26.55 | 21.21 |
Net Worth | 63.14 | 46.82 | 29.64 | 24.3 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Revenue | 179.01 | 137.45 | 111.13 | 92.52 |
yoy growth (%) | 30.23 | 23.67 | 20.12 | 30.19 |
Raw materials | -164.24 | -125.61 | -102.62 | -81.92 |
As % of sales | 91.74 | 91.38 | 92.33 | 88.54 |
Employee costs | -1.49 | -1.44 | -1.38 | -1.29 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | 7.36 | 5.79 | 2.15 | 4.92 |
Depreciation | -0.49 | -0.42 | -0.41 | -0.41 |
Tax paid | -2.01 | -1.54 | -0.62 | -1.7 |
Working capital | 3.61 | 5.53 | -1.22 | 5.89 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 30.23 | 23.67 | 20.12 | 30.19 |
Op profit growth | 30.75 | 108.66 | -46.6 | 61.6 |
EBIT growth | 27.49 | 110.67 | -44.39 | 69.61 |
Net profit growth | 25.87 | 175.9 | -52.26 | 83.35 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,526.35 | 120.29 | 3,65,682.64 | 867.6 | 0.89 | 5,536.99 | 98.75 |
Divis Laboratories Ltd DIVISLAB | 4,559.9 | 76.97 | 1,21,312.5 | 531 | 0.66 | 2,259 | 507.93 |
Cipla Ltd CIPLA | 1,481.45 | 32.36 | 1,20,195.02 | 1,038.4 | 0.57 | 3,444.92 | 346.41 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,092.95 | 31.35 | 1,08,114.81 | 1,405.2 | 0.28 | 3,172.6 | 156.19 |
Dr Reddys Laboratories Ltd DRREDDY | 6,500 | 24.48 | 1,06,298.05 | 1,034.8 | 0.63 | 5,081.8 | 1,453.02 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Managing Director
Lalit Mehta
Director & CFO
Rajesh Mehta
Independent Director
Mahendra Pipalia
Independent Director
Samir Kothary
Independent Director
Renu P Dharod
Executive Director
Megh Mehta
Company Sec. & Compli. Officer
Nishant Kankaria
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Samrat Pharmachem Ltd
Summary
Samrat Pharmachem Ltd was incorporated on June 16, 1992. The Companys principal activities are manufacturing and selling chemicals.The Company floated a new 100% subsidiary company during the year 2003-04 named as Samrat Remedies Limited to carry on activities of Manufacturing of Pharmaceutical Bulk Drugs & Chemicals.
Read More
What is the Samrat Pharmachem Ltd share price today?
The Samrat Pharmachem Ltd shares price on nse is Rs.₹334.8 today.
What is the Market Cap of Samrat Pharmachem Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Samrat Pharmachem Ltd is ₹103.45 Cr. as of 03 Jul ‘24
What is the PE and PB ratio of Samrat Pharmachem Ltd?
The PE and PB ratios of Samrat Pharmachem Ltd is 47.83 and 1.59 as of 03 Jul ‘24
What is the 52 Week High and Low of Samrat Pharmachem Ltd?
The 52-week high/low is the highest and lowest price at which a Samrat Pharmachem Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Samrat Pharmachem Ltd is ₹320 and ₹533.6 as of 03 Jul ‘24
What is the CAGR of Samrat Pharmachem Ltd?
Samrat Pharmachem Ltd's CAGR for 5 Years at 36.88%, 3 Years at 14.03%, 1 Year at -26.05%, 6 Month at -3.97%, 3 Month at -6.88% and 1 Month at -5.91%.
What is the shareholding pattern of Samrat Pharmachem Ltd?
The shareholding pattern of Samrat Pharmachem Ltd is as follows:
Promoters - 48.64 %
Institutions - 3.45 %
Public - 47.91 %
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
